Lantern Pharma selling stockholders may sell 2.24M shares
Selling stockholders of Lantern Pharma may sell up to 2.24 million shares of common stock, according to a SEC filing.
*this image is generated using AI for illustrative purposes only.
Selling stockholders of Lantern Pharma may sell up to 2.24 million shares of common stock, according to a regulatory filing. The potential sale was disclosed in a submission to the United States Securities and Exchange Commission (SEC).
The filing outlines the intention of the selling stockholders to offer these shares in the market. The shares being offered are part of the company's common stock.
Details of the Offering
The following table summarizes the key details of the potential share sale:
| Component | Details |
|---|---|
| Entity | Lantern Pharma |
| Security | Common Stock |
| Maximum Shares | 2.24 million |
| Filing Authority | SEC |
How might the influx of 2.24 million shares affect Lantern Pharma's stock price in the short term?
What are the potential reasons behind the selling stockholders' decision to offload shares at this time?
Could this sale indicate a lack of confidence among early investors or insiders in the company's future performance?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
